PROCESS-DEVELOPMENT FOR THE PRODUCTION OF RECOMBINANT ANTIBODIES USING THE GLUTAMINE-SYNTHETASE (GS) SYSTEM
PROCESS-DEVELOPMENT FOR THE PRODUCTION OF RECOMBINANT ANTIBODIES USING THE GLUTAMINE-SYNTHETASE (GS) SYSTEM
复制标题
DOI:
10.1007/bf02521750
复制
发表时间:
1992-01-01
期刊:
影响因子:
2.2
通讯作者:
HASSELL, T
中科院分区:
文献类型:
--
作者:
BROWN, ME;RENNER, G;HASSELL, T
ConclusionsGS technology has been successfully utilised for the expression of recombinant antibodies. The vectors are capable of stable product accumulation over the extended periods required for large scale manufacture. Large scale processes have been developed giving extremely high antibody yields up to, and in one instance in excess of 1 g/l. It is clear that such systems represent a significant advance over previous technology and will speed the commercial application of such therapeutic products.